NHS

Bi
Split-image illustration contrasting swift private clinic access to Mounjaro for the wealthy versus long NHS queues for obesity patients in the UK.
Hoton da AI ya samar

UK researchers warn NHS rollout of Mounjaro could widen inequalities in obesity care

An Ruwaito ta hanyar AI Hoton da AI ya samar An Binciki Gaskiya

UK specialists say strict early access rules for the weight-loss drug tirzepatide (Mounjaro) risk creating a “two-tier” obesity treatment system, with people who can pay privately getting faster access than those relying on the National Health Service.

A Cl0p ransomware attack has affected patient and staff data at Barts Health NHS. The breach occurred through the organization's Oracle E-Business Suite. Details emerged in a recent report on the incident.

Wannan shafin yana amfani da cookies

Muna amfani da cookies don nazari don inganta shafin mu. Karanta manufar sirri mu don ƙarin bayani.
Ƙi